The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease
Open accessAbstract
BACKGROUND: Approximately 25% of adults regularly experience heartburn, a symptom of gastro-oesophageal reflux disease (GORD). Most patients are treated empirically (without specific diagnostic evaluation e.g. endoscopy. Among patients who have an upper endoscopy, findings range from a normal appearance, mild erythema to severe oesophagitis with stricture formation. Patients without visible damage to the oesophagus have endoscopy negative reflux disease (ENRD). The pathogenesis of ENRD, and its response to treatment may differ from GORD with oesophagitis. OBJECTIVES: Summarise, quantify and compare the efficacy of short-term use of proton pump inhibitors (PPI), H2-receptor antagonists (H2RA) and prokinetics in adults with GORD, treated empirically and in those with endoscopy negative reflux disease (ENRD). SEARCH METHODS: We searched MEDLINE (January 1966 to November 2011), EMBASE (January 1988 to November 2011), and EBMR in November 2011. SELECTION CRITERIA: Randomised controlled trials reporting symptomatic outcome after short-term treatment for GORD using proton pump inhibitors, H2-receptor antagonists or prokinetic agents. Participants had to be either from an empirical treatment group (no endoscopy used in treatment allocation) or from an endoscopy negative reflux disease group (no signs of erosive oesophagitis). DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial quality and extracted data. MAIN RESULTS: Thirty-four trials (1314 participants) were included: fifteen in the empirical treatment group, fifteen in the ENRD group and four in both. In empirical treatment of GORD the risk ratio (RR) for heartburn remission (the primary efficacy variable) in placebo-controlled trials for PPI was 0.37 (two trials, 95% confidence interval (CI) 0.32 to 0.44), for H2RAs 0.77 (two trials, 95% CI 0.60 to 0.99) and for prokinetics 0.86 (one trial, 95% CI 0.73 to 1.01). In a direct comparison PPIs were more effective than H2RAs (seven trials, RR 0.66, 95% CI 0.60 to 0.73) and prokinetics (two trials, RR 0.53, 95% CI 0.32 to 0.87).In treatment of ENRD, the RR for heartburn remission for PPI versus placebo was 0.71 (ten trials, 95% CI 0.65 to 0.78) and for H2RA versus placebo was 0.84 (two trials, 95% CI 0.74 to 0.95). The RR for PPI versus H2RA was 0.78 (three trials, 95% CI 0.62 to 0.97) and for PPI versus prokinetic 0.72 (one trial, 95% CI 0.56 to 0.92). AUTHORS' CONCLUSIONS: PPIs are more effective than H2RAs in relieving heartburn in patients with GORD who are treated empirically and in those with ENRD, although the magnitude of benefit is greater for those treated empirically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Vakil, N., van Zanten, S. V., Kahrilas, P., Dent, J., Jones, R., & the Global Consensus Group (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00630.x · Cited by 3,924
Locke, G., Talley, N., Fett, S., Zinsmeister, A., & Melton, L. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70025-8 · Cited by 2,095
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6514 · Cited by 1,385
Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease
DeVault, K. R., & Castell, D. O. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41217.x · Cited by 1,130
Symptomatic gastroesophageal reflux: Incidence and precipitating factors
Nebel, O. T., Fornes, M. F., & Castell, D. O. (1976) · The American Journal of Digestive Diseases · doi:10.1007/bf01071906 · Cited by 874
Chiba, N., De Gara, C., Wilkinson, J., & Hunt, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9178669 · Cited by 857
Symptoms in gastro-oesophageal reflux disease
Klauser, A. G., Schindlbeck, N. E., & Müller-Lissner, S. A. (1990) · The Lancet · doi:10.1016/0140-6736(90)90287-f · Cited by 745
Updated Guidelines for The Diagnosis and Treatment of Gastroesophageal Reflux Disease
DeVault, K. R., & Castell, D. O. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.1123_a.x · Cited by 544
Carlsson, R., Dent, J., Watts, R., Riley, S., Sheikh, R., Hatlebakk, J., Haug, K., de Groot, G., van Oudvorst, A., Dalväg, A., et al. (1998) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199802000-00004 · Cited by 435
Lind, T., Havelund, T., Carlsson, R., Anker-Hansen, O., Glise, H., Hernqvist, H., Junghard, O., Lauritsen, K., Lundell, L., Pedersen, S. A., et al. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011212 · Cited by 413
Dimenäs, E., Carlsson, G., Glise, H., Israelsson, B., & Wiklund, I. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609095544 · Cited by 380
Prevalence of Symptoms Suggestive of Gastroesophageal Reflux Disease in an Adult Population
Isolauri, J., & Laippala, P. (1995) · Annals of Medicine · doi:10.3109/07853899509031939 · Cited by 319
Venables, T. L., Newland, R. D., Patel, A. C., Hole, J., Wilcock, C., & Turbitt, M. L. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011211 · Cited by 291
Watson, R. G., Tham, T. C., Johnston, B. T., & McDougall, N. I. (1997) · Gut · doi:10.1136/gut.40.5.587 · Cited by 234
Heartburn and globus in apparently healthy people.
Thompson, W., & Heaton, K. W. (1982) · PubMed · Cited by 222
Omeprazole as a diagnostic tool in gastroesophageal reflux disease
Schenk, B. (1998) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(98)80030-9 · Cited by 192
Cimetidine in the treatment of symptomatic gastroesophageal reflux
Behar, J., Brand, D. L., Brown, F. C., Castell, D. O., Cohen, S., Crossley, R. J., Pope, C. E., & Winans, C. S. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90778-3 · Cited by 190
One-Week Omeprazole Treatment in the Diagnosis of Gastro-oesophageal Reflux Disease
F. JOHNSSON, L. W. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850166149 · Cited by 162
Havelund, T., Lind, T., Wiklund, I., Glise, H., Hernqvist, H., Lauritsen, K., Lundell, L., Pedersen, S. A., Carlsson, R., Junghard, O., et al. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00262-2 · Cited by 147
Richter, J. E., Campbell, D. R., Kahrilas, P. J., Huang, B., & Fludas, C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.12.1803 · Cited by 142
Efficacy of Omeprazole for the Treatment of Symptomatic Acid Reflux Disease Without Esophagitis
Richter, J. E., Peura, D. A., Benjamin, S. B., Joelsson, B. E., & Whipple, J. P. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.12.1810 · Cited by 127
A Controlled Trial of Metoclopramide in Symptomatic Gastroesophageal Reflux
McCallum, R. W., Ippoliti, A. F., Cooney, C., & Sturdevant, R. A. L. (1977) · New England Journal of Medicine · doi:10.1056/nejm197702172960702 · Cited by 122
Esophageal Hypersensitivity May Be A Major Cause of Heartburn
Rodriguez-Stanley, S., Robinson, M., Earnest, D. L., Meerveld, B. G., & Miner, P. B. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00806-5 · Cited by 118
van Zanten, S. J. O. V., Chiba, N., Armstrong, D., Barkun, A. N., Thomson, A. B. R., Smyth, S., Escobedo, S., Lee, J., & Sinclair, P. J. J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40280.x · Cited by 117
Wiklund, I. E., Bardhan, K. D., Müller-Lissner, S. A., Bigard, M., Bianchi Porro, G., Ponce, J., Hosie, J., Scott, M., Weir, D. G., Fulton, C., et al. (1998) · PubMed · Cited by 116
Fass, R., Johnson, D. A., Orr, W. C., Han, C., Mody, R., Stern, K., Pilmer, B. L., & Perez, C. M. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.458 · Cited by 103
Fass, R., Chey, W. D., Zakko, S. F., Andhivarothai, N., Palmer, R. N., Pérez, M. C., & Atkinson, S. N. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04013.x · Cited by 93
Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial
Sj, S. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.8.1485 · Cited by 90
Tefera, L. T., Fein, M., Ritter, M. P., et al. (1997) · PubMed · Cited by 89
Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis
Galmiche, J., Fraitag, B., Filoche, B., et al. (1990) · Digestive Diseases and Sciences · doi:10.1007/bf01540415 · Cited by 74
Rush, D. R., Wj, S., Young, T. L., Kirchdoerfer, L. J., Scott-Lennox, J. A., Holverson, H. E., Sabesin, S. M., & Nicholas, T. A. (1995) · PubMed · Cited by 73
Armstrong, D., Paré, P., Pericak, D., & Pyzyk, M. (2001) · PubMed · doi:10.1111/j.1572-0241.2001.4237_a.x · Cited by 72
de Broek, N. T. L.-V., Numans, M. E., Buskens, E., Verheij, T. J., de Wit, N. J., & Smout, A. J. P. M. (2001) · Europe PMC (PubMed Central) · Cited by 57
Self-citationArmstrong, D., van Zanten, S. J. O. V., Barkun, A. N., Chiba, N., Thomson, A. B. R., Smyth, S., Sinclair, P., Chakraborty, B., White, R. J., & The CADET‐HR Study Group (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02466.x · Cited by 57
Cisapride versus ranitidine in the treatment of reflux esophagitis.
Hd, J., Hüttemann, W., & Bouzo, M. (1988) · PubMed · Cited by 57
van Pinxteren, B., Numans, M. E., Bonis, P. A., & Lau, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002095.pub2 · Cited by 49
Self-citationDomperidone, Metoclopramide, and Placebo
Maddern, G. J., Kiroff, G., Leppard, P., & Jamieson, G. G. (1986) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198604000-00006 · Cited by 48
Talley, N. J., Vakil, N. B., Lauritsen, K., van Zanten, S. V., Flook, N. W., Bolling‐Sternevald, E., Persson, T., Björck, E., Lind, T., & ON BEHALF OF THE STARS I STUDY GROUP (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03410.x · Cited by 47
Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire
Johnsson, F., Roth, Y., PEDERSEN, N. ‐. D., & Joelsson, B. E. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00073.x · Cited by 47
Symptom-relieving Effect of Esomeprazole 40 mg Daily in Patients with Heartburn
Johnsson, F., Hatlebakk, J. G., Klintenberg, A.-C., & Román, J. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310002157 · Cited by 44
Meineche-Schmidt, V. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30089.x · Cited by 41
Johnson, D. A., Crawley, J. A., Hwang, C., & Brown, K. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04339.x · Cited by 39
van Pinxteren, B., Numans, M. E., Bonis, P. A., & Lau, J. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002095 · Cited by 32
Self-citationPantoprazole Rapidly Improves Health-Related Quality of Life in Patients With Heartburn
Paré, P., Armstrong, D., Pericak, D., & Pyzyk, M. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200308000-00008 · Cited by 26
van Zanten, S. V., Flook, N. W., Talley, N. J., Vakil, N. B., Lauritsen, K., Bolling‐Sternevald, E., Persson, T., Björck, E., Svedberg, L.-E., & ON BEHALF OF THE STARS II STUDY GROUP (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03409.x · Cited by 25
Juul-Hansen, P., & Rydning, A. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03877.x · Cited by 16
Classification of dyspepsia and response to treatment with proton‐pump inhibitors
Meineche-Schmidt, V. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02243.x · Cited by 15
Rabeprazole-Based Therapy in The Management of Symptomatic Gastroesophageal Reflux Disease
Sloan, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00015-7 · Cited by 13
Cited by
Vakil, N., van Zanten, S. V., Kahrilas, P., Dent, J., Jones, R., & the Global Consensus Group (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00630.x · Cited by 3,924
Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Gerson, L. B., & Vela, M. F. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.444 · Cited by 1,767
Rosen, R., Vandenplas, Y., Singendonk, M., Cabana, M., DiLorenzo, C., Gottrand, F., Gupta, S., Langendam, M., Staiano, A., Thapar, N., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001889 · Cited by 1,557
Fitzgerald, R. C., di Pietro, M., Ragunath, K., Ang, Y., Kang, J.-Y., Watson, P., Trudgill, N., Patel, P., Kaye, P. V., Sanders, S., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305372 · Cited by 1,346
Update of EULAR recommendations for the treatment of systemic sclerosis
Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., Distler, O., Clements, P., Cutolo, M., Czirjak, L., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209909 · Cited by 1,104
“[81] The efficacy of PPI in the treatment of GERD in the general population is well documented in meta-analyses of RCTs.[82-84] In asymptomatic SSc patients, PPI should be used with caution since long-term therapy with PPIs might lead to nutritional deficiencies, possibly due to reduced intestinal absorption, or incre…”
Background
Metadata
- Authors
- Sigterman, K. E., van Pinxteren, B., Bonis, P. A., Lau, J., & Numans, M. E.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-05-31
- Volume
- 2013
- Issue
- 5
- Pages
- CD002095-CD002095
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1935581134
- Cited by
- 507
- References
- 49
- FWCI
- 28.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.